Full Text View
Tabular View
No Study Results Posted
Related Studies
Reduction of the Metabolic Syndrome in Navarra-Spain (RESMENA-S)
This study has been completed.
Study NCT01087086   Information provided by Clinica Universidad de Navarra, Universidad de Navarra

First Received on March 11, 2010.   Last Updated on November 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metabolic Syndrome
Obesity
Diabetes
Cardiovascular Disease
Additional conditions recognized in this trial
Cardiovascular Diseases
Metabolic Syndrome X
More general conditions related to this trial
Body Weight
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Metabolic Diseases
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
Crononutrition
American Heart Association
Additional drug interventions recognized in this trial
Antioxidants
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sponsors listed in this trial
Clinica Universidad de Navarra, Universidad de Navarra
Hospital of Navarra


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services